The review analysed three sets of studies.
Six RCTs were included in the review of large-scale studies on common cold incidence and vitamin C. There were 1,747 participants in the vitamin C group and 1,766 participants in the placebo group.
Five studies were included in the review of British studies on common cold incidence and vitamin C. There were 1,100 participants (581 males and 519 females) in the vitamin C group and 1,674 participants (1,238 males and 436 females) in the placebo group. Three of the studies were RCTs, one was double-blind but not randomised, and one was neither double-blind nor randomised. One of the RCTs used an active placebo of low-dose vitamin C.
Four studies were included in the review of vitamin C intake in British males. There were 597 participants in the vitamin C group and 530 participants in the placebo group. Two of the studies were RCTs, one was double-blind but not randomised, and one was neither double-blind nor randomised.
In the 6 large-scale studies there was no evidence that high-dose vitamin C supplementation decreases common cold incidence in ordinary people (RR 0.99, 95% CI: 0.93, 1.04). In the group of British studies, the 4 studies of vitamin C supplementation for females showed no marked effect on common cold incidence (RR 0.95, 95% CI: 0.86, 1.04). The 4 studies of vitamin C supplementation for male schoolchildren and students showed a statistically-significant reduction in common cold incidence (RR 0.70, 95% CI: 0.60, 0.81).
In the third group of studies on British males, there was a statistically-significant reduction in the number of males with recurrent common cold infections in the grouup receiving vitamin C supplementation (RR 0.54, 95% CI: 0.40, 0.74; p=0.00005).